Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.

11.09.2008

november AG´s management and supervisory board suggest a capital 
decrease at an extraordinary annual meeting aiming at supporting 
november AG´s n-going financial restructuring. As part of resolving 
november AG's on-going financial restructuring, a simpified capital 
decrease in accordance to §§229 ff. AktG from EUR 14.041.515,00 by 
way of 3 to 1 reverse stock split, in order to cover losses and 
cmpensation of value depreciations is suggested to the extraodinary 
annual meeting. The share capital of the company will be reduced by 
one share, which will be acquired gratuitously and collected 
immediately, in order to prevent share fractions. The invitation to 
the extraordinary annual meeting including the draft resolution is to
be released to the public in the ebundesanzeiger soon.

end of announcement                               euro adhoc

Further inquiry note:

Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN: DE000A0S9N72
WKN: A0S9N7
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade